20/20 Gene Systems (Convertible Notes)
Funding Details
- Awarder
- StartEngine
- Date Award
- June 13, 2024
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Premoney Valuation
- $58,400,000
- Valuation
- $58,400,000
Company Info
- Founding Year
- Not provided
- Traction
- This represents an increase of more than 300% over 2020 revenues. With their ability to enhance their operations with COVID testing, they ranked no. 131 on the Inc. 5000 list of America’s fastest-growing companies in 2022.
- Revenue Amount
- $30,000,000
- Organizations Involved
- China’s Ping An Ventures, Keiretsu Forum, family offices, over 8,000 crowd investors
- Founders
- Jonathan Cohen, Jiming Zhou, Michael Lebowitz
- Company Description
- 20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug
- Market
- Medical Diagnostics
- Location
- Gaithersburg, MD, US
- Coinvestors
- China’s Ping An Ventures, Keiretsu Forum, family offices, over 8,000 crowd investors